Whitepaper: Navigating ICH Q3E: Implications for Extractables and Leachables (E&L) Evaluation
Published Jan 07, 2026
Learn how DLRC provides tailored regulatory consultancy services to help clients navigate complex challenges and accelerate their success.
DLRC worked with a small pharmaceutical company specialising in generic drugs. This client embarked on significant changes to its manufacturing process to improve efficiency and cost effectiveness. They sought essential support from DLRC to develop a highly effective regulatory strategy and deliver the required CMC (Chemistry, Manufacturing, and Controls) input to meet strict regulatory standards.
The project posed a multifaceted challenge due to the intricate nature and volume of manufacturing changes. A high degree of interdependence among these changes required a comprehensive submission strategy. Furthermore, a due diligence assessment of the dossier was needed, as unforeseen issues arose during the manufacturing changes, demanding additional interactions with regulatory authorities. The involvement of third-party stakeholders, including Contract Manufacturing Organisations (CMOs) and external advisors, further compounded the complexity.
To navigate these challenges, DLRC adopted a collaborative approach, integrating project management, CMC expertise, and our regulatory operations teams. This dynamic collaboration was instrumental in meeting the project requirements.
DLRC prioritised timely and transparent communication with the client, third parties, and regulatory authorities. This engagement resulted in the development of a clear and well-coordinated regulatory submission strategy. DLRC worked with the regulatory authorities to negotiate an effective grouping of variations across multiple licences, including up to 39 changes.
DLRC’s dedicated CMC team held comprehensive reviews and also provided expert advice on various aspects of the necessary dossier updates. Their input significantly enhanced the value and robustness of the submission packages. DLRC’s rigorous quality system ensured impeccable document traceability and streamlined submission management across diverse teams, ensuring seamless execution.
DLRC’s unrivalled CMC and regulatory expertise was demonstrated in a regulatory strategy that exceeded expectations. Only one minor request for further information (RFI) was received from the regulatory authorities. Demonstrating our proficiency, DLRC promptly responded to this RFI. As a testament to the quality of our work, full approval swiftly followed, marking success for our client and DLRC’s dedication to excellence.
The successful collaboration between DLRC and our client has not only ensured the swift approval of crucial manufacturing changes but has also laid the foundation for future success. Our client can now move forward with implementing their desired manufacturing process changes efficiently and without delay.
If you, too, seek the support and expertise of DLRC in your regulatory work, we invite you to reach out to us. Together, we can turn your regulatory challenges into successes.
Published Jan 07, 2026
Published Dec 02, 2025
Published Nov 27, 2025
Published Nov 25, 2025
Published Nov 24, 2025
Published Nov 24, 2025
Published Nov 24, 2025
Published Nov 14, 2025
Published Oct 20, 2025